PLAINSBORO, N.J., April 27, 2016 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that the Company is prepared to launch Omnigraft™ Dermal Regeneration Matrix in June 2016, pending receipt of final U.S. Food and Drug Administration (FDA) packaging approval. The FDA approved the PMA Supplement for Integra® Dermal Regeneration […]